John Hathaway - 31 Dec 2024 SCHEDULE 13G Report for Medicus Pharma Ltd. Common shares, no par value (MDCX)

Filing Manager: John Hathaway
Reporting Manager: John Hathaway
Security: Medicus Pharma Ltd. Common shares, no par value
Symbol: MDCX
Shares outstanding: 11.8M shares
Disclosed Ownership: 801K shares
Ownership: 6.8%
Form type: SCHEDULE 13G
Filing time: 10 Feb 2025, 10:51:36 UTC
Date of event: 31 Dec 2024
Next filing: 12 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Hathaway	6.8%	801K	801K	0	/s/ John Hathaway	John Hathaway
SkinJect Partners LLC	6.8%	801K	801K	0	/s/ John Hathaway	John Hathaway, Managing Director